These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
4405 related items for PubMed ID: 11967899
1. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ. J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899 [Abstract] [Full Text] [Related]
2. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma. Machiavelli MR, Romero AO, Pérez JE, Lacava JA, Domínguez ME, Rodríguez R, Barbieri MR, Romero Acuña LA, Romero Acuña JM, Langhi MJ, Amato S, Ortiz EH, Vallejo CT, Leone BA. Cancer J Sci Am; 1998 May; 4(2):125-31. PubMed ID: 9554929 [Abstract] [Full Text] [Related]
3. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer. Escobar PF, Patrick RJ, Rybicki LA, Hicks D, Weng DE, Crowe JP. Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475 [Abstract] [Full Text] [Related]
10. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR. Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [Abstract] [Full Text] [Related]
11. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ, Bland KI. J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459 [Abstract] [Full Text] [Related]
12. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Hatoum HA, Jamali FR, El-Saghir NS, Musallam KM, Seoud M, Dimassi H, Abbas J, Khalife M, Boulos FI, Tawil AN, Geara FB, Salem Z, Shamseddine AA, Al-Feghali K, Shamseddine AI. Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200 [Abstract] [Full Text] [Related]
13. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. Sataloff DM, Mason BA, Prestipino AJ, Seinige UL, Lieber CP, Baloch Z. J Am Coll Surg; 1995 Mar; 180(3):297-306. PubMed ID: 7874340 [Abstract] [Full Text] [Related]
14. Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy. Buchholz TA, Hill BS, Tucker SL, Frye DK, Kuerer HM, Buzdar AU, McNeese MD, Singletary SE, Ueno NT, Pusztai L, Valero V, Hortobagyi GN. Cancer J; 2001 Mar; 7(5):413-20. PubMed ID: 11693900 [Abstract] [Full Text] [Related]
19. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients. Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J. Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1062-73. PubMed ID: 15234040 [Abstract] [Full Text] [Related]
20. Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy. Gonzalez-Angulo AM, McGuire SE, Buchholz TA, Tucker SL, Kuerer HM, Rouzier R, Kau SW, Huang EH, Morandi P, Ocana A, Cristofanilli M, Valero V, Buzdar AU, Hortobagyi GN. J Clin Oncol; 2005 Oct 01; 23(28):7098-104. PubMed ID: 16192593 [Abstract] [Full Text] [Related] Page: [Next] [New Search]